Related Tags >> Pfizer Exubera insulin Sanofi-Aventis

Nektar Therapeutics News

Most Popular Nektar Therapeutics Story

Inhaled insulin lung cancer warning riles investors

April 9, 2008 — 6:59am ET

The inhaled insulin field got blitzed again today after Nektar Therapeutics and Pfizer reported an increased number of... Read more...

Nektar Therapeutics Press Releases

NKT Therapeutics Closes Series A Venture Round Led by SV Life Sciences and MedImmune Ventures, Inc.
Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EOR
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale
PRESS RELEASE: Pfizer and Nektar Reach Agreement on Exubera

Latest Headlines

NKT banks $8M in Series A
March 16, 2009
Novartis pays $115M for Nektar pulmonary assets
October 21, 2008
C&L: Somnus names executive team
May 28, 2008
A deluge of pre-ASCO data hits the market
May 16, 2008
Inhaled insulin lung cancer warning riles investors
April 9, 2008
ALSO NOTED: Osiris inks $224M contract; Baxter and Nektar to collaborate;and much more...
January 7, 2008
ALSO NOTED: FDA says no to Indevus; Nektar gets sweetened deal with Baxter; Akela pulls public offering; and much more...
December 20, 2007
C&L: Somaxon names interim CEO
December 12, 2007
Pfizer gives Nektar $135M for Exubera settlement
November 13, 2007
Pearl Therapeutics finds $15.5M in first VC round
September 6, 2007
C&L: Worland tapped for Anadys post
August 29, 2007
DEALS: Pfizer, Icagen ink development pact
August 16, 2007
Nektar scores $175M pact for pneumonia therapy
August 6, 2007
C&L: Stonehouse tapped to run Biocryst
January 9, 2007
ALSO NOTED: Dynavax shares slump on inconclusive trial; iCo licenses rights to CAT-213; and much more...
January 7, 2007
ALSO NOTED: Serono inks pact with Syntonix; Sanofi mentioned as possible BMS suitor; and much more...
September 17, 2006
ALSO NOTED: Nektar closes UK site; Martines resigns from NSP; and much more...
July 26, 2006
ALSO NOTED: TransPharma raises $18M; Biogen Idec, Elan re-release Tysabri; and much more...
July 23, 2006
Nektar settles university patent fight
July 6, 2006
ALSO NOTED: Nektar gains fast track for lung infection drug; Vertex reports positive hep C data; and much more...
May 21, 2006

Paid Research Reports

More Research Reports >>